We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
    • Leafly.deGerman flag
  • Help
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Politics

Rohrabacher–Blumenauer Renewal OK’d by Congressional Committee

Bruce KennedyPublished on May 17, 2018 · Last updated July 28, 2020

A powerful Congressional committee on Thursday voted to extend federal protections for state-legal medical marijuana. It’s the latest example of how Congress is progressing on cannabis, one small step at a time.

The US House Appropriations Committee passed by voice vote an amendment introduced by US Rep. David Joyce (R-OH) that would ban the Department of Justice from using its funds to intervene with state laws that allow the growth, distribution, and use of cannabis for medical use.

The bill will now be considered by the full House of Representatives.

Great news for states’ rights and those suffering severe pain. @HouseAppropsGOP Fiscal Year 2019 Commerce, Justice and Science Appropriations Bill will include an amendment offered by myself protecting states’ rights regarding the use of medical marijuana.

— Dave Joyce (@RepDaveJoyce) May 17, 2018

The spending provision has technically been in effect since 2014, first as the Rohrabacher–Farr amendment and later called the Rohrabacher–Blumenauer amendment. But conservative Republicans—and particularly Rep. Pete Sessions (R-TX), the House Rules Committee chairman and an avowed cannabis legalization opponent—have worked to keep the amendment from making it to a floor vote.

“For the first time ever our Rohrabacher-Blumenauer language passed by voice in Committee,” Rep. Earl Blumenauer (D-OR) tweeted after the vote, adding that further steps need to be taken to protect adult-use legalization. “MMJ protections are not enough. We need to expand to adult use. But today’s action in Committee is another sign that momentum is building.”

Cannabis industry advocates say the committee’s actions are historic in scope.

“It’s a tide-turner for our industry,” said Saphira Galoob, CEO and principal of The Liaison Group, a Washington, DC, lobbying firm that works on federal cannabis policies.

“Given that federal standalone legislation is much harder and more time-consuming to pass, [and] given that appropriations bills pass every year, having this in the base bill opens up our opportunity and gives us traction … to get banking protections for example, veterans’ access (to medical cannabis), and downstream hopefully to include adult consumption,” she told Leafly.

Galoob also credited what she called the “new generation of credible conservative cannabis champions who understand the importance of protecting the laboratories of democracy: the robust state [medical cannabis] programs that are flourishing.”

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries

She commended Joyce, a former prosecutor, for his understanding of “how important it is that state and federal law be reconciled, to allow this industry to grow and thrive.”

That praise was echoed by Justin Strekal, political director of NORML.

“We thank Representative Joyce for his leadership to protect the 46 states that have reformed their marijuana policies and the over 2 million patients that they serve,” Strekal said in a statement.

This is a major, major development because it circumvents the seemingly insurmountable roadblock that House Rules Chair Pete Sessions has thrown up to allowing marijuana amendments on the floor for the past several years. https://t.co/saBYhL9KW7

— Tom Angell 🌳📰 (@tomangell) May 17, 2018

Don Murphy, director of conservative outreach for the Marijuana Policy Project, called the amendment just the latest sign that support is growing in Congress for marijuana policy reforms.

“Republicans are joining with Democrats to protect compassionate state medical marijuana programs from federal interference,” he said in a statement. “The strong bipartisan support we’re seeing in Congress mirrors public opinion, as polls show an overwhelming majority of both major parties support legal access to medical marijuana. At this point, opponents probably want to avoid being on the record voting against sick patients and states’ rights, which could explain why the committee held a voice vote.”

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
Congresslaw enforcementlegislationrohrabacher-blumenauer
Bruce Kennedy
Bruce Kennedy
Bruce Kennedy is an award-winning reporter, editor, and producer based in Colorado. He has covered the legal cannabis industry since 2010.
View Bruce Kennedy's articles

The latest in Politics

  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
  • Analysis: Don’t hold your breath for legalization under Trump 2.0 image
    Analysis: Don’t hold your breath for legalization under Trump 2.0
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.